Dermapharm Holding: AGM Approves €0.90/Share Dividend

• Dermapharm Holding SE's Annual General Meeting approved a dividend distribution of EUR 0.90 per share.
• The actions of the Board of Management and Supervisory Board for the financial year 2024 were ratified with 99.2% and 89.4% majority votes, respectively.
• Grant Thornton AG was re-elected as the auditor for the current financial year, and RSM Ebner Stolz GmbH & Co. KG was chosen for sustainability reporting, pending national law changes.
• Dermapharm's revenue and net profit exceeded forecasts in 2024, and the company set strategic priorities for future growth.
• The company expects consolidated revenue of EUR 1,160–1,200 million and adjusted EBITDA of EUR 322–332 million for 2025.
• Dermapharm focuses on profitable growth through strong brands, innovation, and sustainable value creation, with a particular emphasis on the "Branded pharmaceuticals" segment.

The next important date, Dermapharm Holding SE - Annual General Meeting, at Dermapharm Holding is on 26.06.2025.

The price of Dermapharm Holding at the time of the news was 34,75EUR and was up +0,43 % compared with the previous day.
At this time, the index SDAX was at 17.125,93PKT (+1,01 %).

Dermapharm Holding

0,00 %

+1,89 %

+0,57 %

-2,50 %

-2,09 %

-28,04 %

-22,56 %

+18,07 %

ISIN:DE000A2GS5D8WKN:A2GS5D

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• Max

Diskutieren Sie über die enthaltenen Werte

Dermapharm Holding

Dermapharm Holding 0,00 % Aktie

1 Aufrufe heute

BörsenBot 29.06.25, 08:00